{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T01:45:54Z","timestamp":1791942354357,"version":"4.3.4"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T00:00:00Z","timestamp":1746144000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Most cases of acute promyelocytic leukemia (APL) are driven by the PML::RARA fusion gene, which is sensitive to differentiation induction therapy comprising of all-trans retinoic acid (ATRA) and arsenic trioxide (ATO). Treatment with ATRA plus ATO has achieved remarkable clinical outcome in patients with typical APL. However, 5% of patients still died from relapsed\/refractory disease, predominantly high-risk APL and variant APL. The diagnosis and treatment of variant APL remain challenging. Here, we report a case of TFG::RARA variant APL recognized by targeted RNA sequencing. The patient achieved a sustained complete response following treatment with venetoclax combined with ATRA. Currently, the overall survival (OS) of the patient has exceeded 30 months, and the progression-free survival (PFS) has reached 29 months. Our results suggest that venetoclax combined with ATRA may be an ideal treatment option for patients with TFG::RARA variant APL.<\/jats:p>","DOI":"10.3389\/fonc.2025.1529640","type":"journal-article","created":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T11:44:04Z","timestamp":1746186244000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Venetoclax combined with ATRA shows promising therapeutic potential for TFG:: RARA variant APL: a case report"],"prefix":"10.3389","volume":"15","author":[{"given":"Xianfeng","family":"Ouyang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianguo","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenfeng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qibao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,5,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.871590","article-title":"Atypical rearrangements in APL-like acute myeloid leukemias: molecular characterization and prognosis","volume":"12","author":"Guarnera","year":"2022","journal-title":"Front  Oncol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12040967","article-title":"Classic and variants APLs, as viewed from a therapy response","volume":"12","author":"Geoffroy","year":"2020","journal-title":"Cancers"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/347558a0","article-title":"The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor alpha gene to a novel transcribed locus","volume":"347","author":"de Th\u00e9","year":"1990","journal-title":"Nature"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(91)90113-d","article-title":"The PML-RAR alpha fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR","volume":"66","author":"de Th\u00e9","year":"1991","journal-title":"Cell"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1126\/science.2218500","article-title":"Molecular analysis of acute promyelocytic leukemia breakpoint cluster region on chromosome 17","volume":"249","author":"Borrow","year":"1990","journal-title":"Sci (New York NY)"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.89.7.2694","article-title":"Reverse transcription polymerase chain reaction for the rearranged retinoic acid receptor alpha clarifies diagnosis and detects minimal residual disease in acute promyelocytic leukemia","volume":"89","author":"Miller","year":"1992","journal-title":"Proc Natl Acad Sci United States America"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022018020","article-title":"APL: Nemo finds its sea anemone","volume":"140","author":"Wang","year":"2022","journal-title":"Blood"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-07-102798","article-title":"Acute promyelocytic leukemia: from highly fatal to highly curable","volume":"111","author":"Wang","year":"2008","journal-title":"Blood"},{"key":"B9","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s40364-021-00284-x","article-title":"Current views on the genetic landscape and management of variant acute promyelocytic leukemia","volume":"9","author":"Zhang","year":"2021","journal-title":"biomark Res"},{"key":"B10","article-title":"A new morphologic classification system for acute promyelocytic leukemia distinguishes cases with underlying PLZF\/RARA gene rearrangements","volume":"96","author":"Sainty","year":"2000","journal-title":"Blood"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V87.3.882.bloodjournal873882","article-title":"The t(5;17) variant of acute promyelocytic leukemia expresses a nucleophosmin-retinoic acid receptor fusion","volume":"87","author":"Redner","year":"1996","journal-title":"Blood"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/ng0997-109","article-title":"Fusion of retinoic acid receptor alpha to NuMA, the nuclear mitotic apparatus protein, by a variant translocation in acute promyelocytic leukaemia","volume":"17","author":"Wells","year":"1997","journal-title":"Nat Genet"},{"key":"B13","article-title":"A new variant translocation in acute promyelocytic leukaemia: molecular characterization and clinical correlation","volume":"10","author":"Wells","year":"1996","journal-title":"Leukemia"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/8.9.1741","article-title":"The signal transducer and activator of transcription STAT5b gene is a new partner of retinoic acid receptor alpha in acute promyelocytic-like leukaemia","volume":"8","author":"Arnould","year":"1999","journal-title":"Hum Mol Genet"},{"key":"B15","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/j.1600-0609.2009.01324.x","article-title":"Acute promyelocytic leukemia harboring a STAT5B-RARA fusion gene and a G596V missense mutation in the STAT5B SH2 domain of the STAT5B-RARA","volume":"83","author":"Iwanaga","year":"2009","journal-title":"Eur J Haematol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-01-264432","article-title":"BCOR as a novel fusion partner of retinoic acid receptor alpha in a t(X;17)(p11;q12) variant of acute promyelocytic leukemia","volume":"116","author":"Yamamoto","year":"2010","journal-title":"Blood"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.cancergen.2015.01.008","article-title":"Successful treatment of acute promyelocytic leukemia with a t(X;17)(p11.4;q21) and BCOR-RARA fusion gene","volume":"208","author":"Ichikawa","year":"2015","journal-title":"Cancer Genet"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-022-03289-9","article-title":"Development of physiology based pharmacokinetic model to predict the drug interactions of voriconazole and venetoclax","volume":"39","author":"Dong","year":"2022","journal-title":"Pharm Res"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2018.09.012","article-title":"TFG-RARA: A novel fusion gene in acute promyelocytic leukemia that is responsive to all-trans retinoic acid","volume":"74","author":"Chong","year":"2018","journal-title":"Leukemia Res"},{"key":"B20","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/febs.2017.284.issue-1","article-title":"The calcium-binding protein ALG-2 promotes endoplasmic reticulum exit site localization and polymerization of Trk-fused gene (TFG) protein","volume":"284","author":"Kanadome","year":"2017","journal-title":"FEBS J"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1217197110","article-title":"Inhibition of TFG function causes hereditary axon degeneration by impairing endoplasmic reticulum structure","volume":"110","author":"Beetz","year":"2013","journal-title":"Proc Natl Acad Sci United States America"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgs164","article-title":"The TFG-TEC fusion gene created by the t(3;9) translocation in human extraskeletal myxoid chondrosarcomas encodes a more potent transcriptional activator than TEC","volume":"33","author":"Lim","year":"2012","journal-title":"Carcinogenesis"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1038\/s41467-020-15955-w","article-title":"Proteogenomics analysis unveils a TFG-RET gene fusion and druggable targets in papillary thyroid carcinomas","volume":"11","author":"Krishnan","year":"2020","journal-title":"Nat Commun"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.22737","article-title":"Novel TG-FGFR1 and TRIM33-NTRK1 transcript fusions in papillary thyroid carcinoma","volume":"58","author":"Pfeifer","year":"2019","journal-title":"Genes Chromosomes Cancer"},{"key":"B25","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V94.9.3265","article-title":"TRK-fused gene (TFG) is a new partner of ALK in anaplastic large cell lymphoma producing two structurally different TFG-ALK translocations","volume":"94","author":"Hern\u00e1ndez","year":"1999","journal-title":"Blood"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-016-2622-1","article-title":"Prognostic factors in acute promyelocytic leukemia: strategies to define high-risk patients","volume":"95","author":"Testa","year":"2016","journal-title":"Ann Hematol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-08-868752","article-title":"Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia","volume":"133","author":"DiNardo","year":"2019","journal-title":"Blood"},{"key":"B28","doi-asserted-by":"publisher","first-page":"e28076","DOI":"10.1097\/MD.0000000000028076","article-title":"Relapsed\/refractory acute promyelocytic leukemia with RARA-LBD region mutation was salvaged by venetoclax: A case report","volume":"100","author":"Li","year":"2021","journal-title":"Medicine"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.v197.5","article-title":"Venetoclax for arsenic-resistant acute promyelocytic leukaemia","volume":"197","author":"Wang","year":"2022","journal-title":"Br J Haematol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.v195.2","article-title":"A novel HNRNPC-RARA fusion in acute promyelocytic leukaemia lacking PML-RARA rearrangement, sensitive to venetoclax-based therapy","volume":"195","author":"Liu","year":"2021","journal-title":"Br J Haematol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.v199.5","article-title":"Differentiation therapy using low-dose venetoclax in a variant acute promyelocytic leukaemia carrying ZBTB16-RARA","volume":"199","author":"Li","year":"2022","journal-title":"Br J Haematol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1097\/BS9.0000000000000111","article-title":"Treatment of STAT5b-RARA positive acute promyelocytic leukemia by Venetoclax combining with homoharringtonine, cytarabine: A case report and literature review","volume":"4","author":"Zhang","year":"2022","journal-title":"Blood Sci (Baltimore Md)"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.828852","article-title":"Clinical response to venetoclax and decitabine in acute promyelocytic leukemia with a novel RARA-THRAP3 fusion: A case report","volume":"12","author":"Song","year":"2022","journal-title":"Front  Oncol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1028651","article-title":"Case report: Identification of a novel HNRNPC::RARG fusion in acute promyelocytic leukemia lacking RARA rearrangement","volume":"12","author":"Ding","year":"2022","journal-title":"Front  Oncol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1002\/mc.23671","article-title":"Venetoclax overcomes resistance to all-trans retinoic acid in a variant acute promyelocytic leukemia with TNRC18::RARA fusion","volume":"63","author":"Xu","year":"2024","journal-title":"Mol Carcinogenesis"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1084\/jem.193.4.531","article-title":"BCL-2 cooperates with promyelocytic leukemia retinoic acid receptor alpha chimeric protein (PMLRARalpha) to block neutrophil differentiation and initiate acute leukemia","volume":"193","author":"Kogan","year":"2001","journal-title":"J Exp Med"},{"key":"B37","doi-asserted-by":"publisher","first-page":"115314","DOI":"10.1016\/j.biopha.2023.115314","article-title":"Targeting DHODH reveals therapeutic opportunities in ATRA-resistant acute promyelocytic leukemia","volume":"166","author":"Yang","year":"2023","journal-title":"Biomed Pharmacother"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1529640\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T11:44:04Z","timestamp":1746186244000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1529640\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,2]]},"references-count":37,"alternative-id":["10.3389\/fonc.2025.1529640"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1529640","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,2]]},"article-number":"1529640"}}